ALA-1000, a sustained released buprenorphine injectable for opioid use disorder or chronic pain

Booth No: N614

Characteristic

ALA-1000 is a long-acting injection for treating opioid use disorder or chronic pain using Alar self-developed In-Relar sustained release drug delivery platform. ALA-1000 is a globally unique injectable that can steadily release buprenorphine, enabling maintenance of the therapeutic exposure over three months. ALA-1000 solves the problems existing in conventional medicines including missed dose, low compliance, and risk of drug abuse and misuse. On the strength of its convenience and efficacy, ALA-1000 can improve patients' quality of life, reduce the frequency of visits, and help the patients return to normal life.

Menu

ALA-1000, a sustained released buprenorphine injectable for opioid use disorder or chronic pain

Characteristic

Other Products

Products you may be interested in

Highest Rated Products